JP2019534299A - Process for producing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride - Google Patents

Process for producing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride Download PDF

Info

Publication number
JP2019534299A
JP2019534299A JP2019523878A JP2019523878A JP2019534299A JP 2019534299 A JP2019534299 A JP 2019534299A JP 2019523878 A JP2019523878 A JP 2019523878A JP 2019523878 A JP2019523878 A JP 2019523878A JP 2019534299 A JP2019534299 A JP 2019534299A
Authority
JP
Japan
Prior art keywords
compound
general formula
solvent
temperature
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019523878A
Other languages
Japanese (ja)
Other versions
JP6816274B2 (en
Inventor
フン キム,ヨン
フン キム,ヨン
ウ ペク,ヒョン
ウ ペク,ヒョン
チン リ,ヒョン
チン リ,ヒョン
キョ カン,サン
キョ カン,サン
キ チャン,ソン
キ チャン,ソン
チョ イム,クン
チョ イム,クン
Original Assignee
エスティー ファーム カンパニー リミテッド
エスティー ファーム カンパニー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エスティー ファーム カンパニー リミテッド, エスティー ファーム カンパニー リミテッド filed Critical エスティー ファーム カンパニー リミテッド
Publication of JP2019534299A publication Critical patent/JP2019534299A/en
Application granted granted Critical
Publication of JP6816274B2 publication Critical patent/JP6816274B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/22Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of other functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • C07C247/02Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/08Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated
    • C07C247/10Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本発明は、(S)-N1−(2-アミノエチル)-3-(4-アルコキシフェニル)プロパン-1,2-ジアミン三塩酸塩を製造する新規な方法に関する。The present invention relates to a novel process for preparing (S) -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.

Description

本発明は、(S)-N−(2-アミノエチル)-3-(4-アルコキシフェニル)プロパン-1,2-ジアミン三塩酸塩を製造する新規な方法に関する。 The present invention relates to a novel process for preparing (S) —N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.

EOVIST(登録商標)は、磁気共鳴映像法(MRI)用の常磁性造影剤であって、血管、組織、及び他の非骨性組織のMRIに用いられ、特に肝組織の異常診断に有用である。EOVIST(登録商標)は、薬学的有効成分としてガドキセテート二ナトリウム(gadoxetate disodium)を含み、725.72の分子量、GdC232811Naの化学式、及びガドリニウム(4S)−4−(4-エトキシベンジル)-3,6,9-トリス(カルボキシラトメチル)−3,6,9−トリアザウンデカン酸二ナトリウム塩の構造式を有する。ガドキセテート二ナトリウムは、水溶液中で下記の一般式(a)の構造を有する。 EOVIST (registered trademark) is a paramagnetic contrast agent for magnetic resonance imaging (MRI) and is used for MRI of blood vessels, tissues, and other non-osseous tissues, and is particularly useful for diagnosing abnormalities in liver tissues. is there. EOVIST® contains gadoxetate disodium as a pharmaceutically active ingredient, has a molecular weight of 725.72, a chemical formula of GdC 23 H 28 N 3 O 11 Na 2 , and gadolinium (4S) -4- ( It has the structural formula of 4-ethoxybenzyl) -3,6,9-tris (carboxylatomethyl) -3,6,9-triazaundecanoic acid disodium salt. Gadoxetate disodium has the structure of the following general formula (a) in an aqueous solution.

一般式(a)の化合物を合成するために(S)−N−(2-アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミンから中間体である(S)−2,2' −(2−((2-(ビス(カルボキシメチル)アミノ)−3−(4−エトキシフェニル)プロピル)カルボキシメチル)アミノ)エチルアザンジイル)二酢酸を合成する方法は、中国特許出願CN104761461に開示されている。しかし、市販の化合物である4−ブロモフェネトールから反応物として用いられる(S)−N−(2-アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩を製造する方法を開示する文献はない。 In order to synthesize the compound of the general formula (a), (S) -N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine is an intermediate. 2,2 ′-(2-((2- (bis (carboxymethyl) amino) -3- (4-ethoxyphenyl) propyl) carboxymethyl) amino) ethylazanediyl) diacetic acid is a Chinese patent. It is disclosed in application CN104761461. However, (S) —N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride used as a reactant from the commercially available compound 4-bromophenetole There is no literature which discloses the method of manufacturing.

本発明者らは、ガドキセテート二ナトリウム製造に用いることができる中間体として、(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩を提供する方法を見出すために長い間研究を行い、その結果、1−ハロ−4−エトキシベンゼンからのグリニャールカップリングを含む一連のプロセスが(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の効率的な大量生産を可能にする経済的で簡単な方法であることを確認し、本発明を完成した。 As intermediates that can be used in the production of gadoxetate disodium, the present inventors have (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride. Long-term studies have been carried out to find ways to provide salts, and as a result, a series of processes involving Grignard coupling from 1-halo-4-ethoxybenzene has been performed (S) -N 1- (2-aminoethyl) It was confirmed that this was an economical and simple method enabling efficient mass production of -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride, and the present invention was completed.

前記目的を達成するために、本発明の例示的な実施形態は以下の段階を含む(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩を製造するための方法を提供する:
(1)一般式(1)の化合物のグリニャールカップリングによって一般式(2)の化合物を製造する段階;(2)アジ化ナトリウムとの反応において、一般式(2)の化合物をアジド置換によって一般式(3)の化合物を製造する段階;(3)トリフェニルホスフィンを用いて一般式(3)の化合物を環化によって保護されたアミノ基を有する一般式(4)のアジリジン誘導体を製造する段階;(4)一般式(4)の化合物を開環することによって一般式(5)の化合物を製造する段階;及び(5)一般式(5)の化合物のアミノ保護基を除去するための反応によって一般式(6)の化合物を製造する段階:
(式中、Xはブロモまたはクロロであり、
RはC1-6アルキルである。)。
To achieve the above object, an exemplary embodiment of the present invention includes (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-, which comprises the following steps: A method for producing diamine trihydrochloride is provided:
(1) A step of producing a compound of the general formula (2) by Grignard coupling of a compound of the general formula (1); (2) In the reaction with sodium azide, the compound of the general formula (2) is generally substituted by azide substitution. A step of producing a compound of formula (3); (3) a step of producing an aziridine derivative of general formula (4) having an amino group protected by cyclization of the compound of general formula (3) with triphenylphosphine. (4) a step of producing a compound of the general formula (5) by opening the compound of the general formula (4); and (5) a reaction for removing the amino protecting group of the compound of the general formula (5) Preparing the compound of general formula (6) by:
Wherein X is bromo or chloro,
R is C 1-6 alkyl. ).

例えば、Xはブロモであってもよい。   For example, X may be bromo.

例えば、Rはエチルであってもよい。   For example, R may be ethyl.

従来、(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法は、水酸基を含む化合物を用いて、さらにアルコキシ、 例えば、エトキシを導入する段階を含むことによって行われていて、また、不必要な官能基を除去するためにPd/Cを用いてさらなる水素化を必要とするなどの不都合があった。したがって、本発明は商業的に入手可能であり、そのような不要なプロセスを最小限に抑えた簡便に利用できる簡単な化合物を用いて(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法を合理化することを技術的な特徴とする。 Conventionally, a method for producing (S) —N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride uses a compound containing a hydroxyl group, further alkoxy, For example, it was carried out by including a step of introducing ethoxy, and there was a disadvantage that further hydrogenation was required using Pd / C to remove unnecessary functional groups. Thus, the present invention is commercially available and using (S) -N 1- (2-aminoethyl) -3 with a simple compound that is readily available with minimal such unnecessary processes. It is technically characterized to streamline the process for producing-(4-alkoxyphenyl) propane-1,2-diamine trihydrochloride.

具体的には、段階(1)はグリニャールカップリングにより行うことができる。例えば、段階(1)は、一般式(1)の化合物を金属または有機金属化合物と反応させることによってグリニャール化合物を製造する段階(1-1);及び一般式(7)の化合物とグリニャール化合物を反応させる段階(1-2)によって行うことができる:
Specifically, step (1) can be performed by Grignard coupling. For example, in step (1), a step (1-1) of producing a Grignard compound by reacting a compound of the general formula (1) with a metal or an organometallic compound; and a compound of the general formula (7) and a Grignard compound It can be carried out by reacting step (1-2):

段階(1-1)の金属または有機金属化合物は、グリニャール化合物として製造することができる当該分野で公知の任意の物質であってもよいが、これに限定されない。例えば、前記化合物はマグネシウムであってもよいが、これに限定されない。   The metal or organometallic compound in step (1-1) may be any substance known in the art that can be produced as a Grignard compound, but is not limited thereto. For example, the compound may be magnesium, but is not limited thereto.

段階(1)の溶媒は、限定されず、グリニャールカップリングに一般的に用いられる任意の有機溶媒であってもよい。例えば、前記溶媒はテトラヒドロフラン(THF)、1,4-ジオキサン、ジエチルエーテル、またはそれらの混合物であってもよく、具体的には、テトラヒドロフラン(THF)であってもよいが、これに限定されない。   The solvent in step (1) is not limited and may be any organic solvent generally used for Grignard coupling. For example, the solvent may be tetrahydrofuran (THF), 1,4-dioxane, diethyl ether, or a mixture thereof, specifically tetrahydrofuran (THF), but is not limited thereto.

具体的には、段階(1-1)は、20℃〜60℃の温度で行われてもよい。段階(1-1)は、ハロゲン化合物と金属とを反応させてグリニャール化合物を製造する段階であり、前記段階を高温で行うと望ましくない副反応を引き起こす可能性がある。したがって、20℃〜30℃の低温で反応物をゆっくりと添加した後に、反応のために温度を上げてもよいが、温度を調整する方法はこれに限定されない。   Specifically, the step (1-1) may be performed at a temperature of 20 ° C. to 60 ° C. Step (1-1) is a step of producing a Grignard compound by reacting a halogen compound and a metal. If the step is performed at a high temperature, an undesirable side reaction may be caused. Therefore, after slowly adding the reactants at a low temperature of 20 ° C. to 30 ° C., the temperature may be increased for the reaction, but the method of adjusting the temperature is not limited thereto.

また、段階(1-2)は−20℃〜30℃、具体的には0℃〜20℃の温度で行ってもよいが、これに限定されない。(1-2)で用いられる反応物は反応性が高く、そのため、低温で反応を行うことが望ましい。例えば、−5℃の低い温度で反応物を添加すると、望ましくない方向への反応を妨げられることができる。   Further, the step (1-2) may be performed at a temperature of -20 ° C to 30 ° C, specifically 0 ° C to 20 ° C, but is not limited thereto. The reactant used in (1-2) has high reactivity, and therefore it is desirable to perform the reaction at a low temperature. For example, adding the reactant at a low temperature of −5 ° C. can prevent the reaction in an undesirable direction.

段階(1-2)は、触媒としてルイス酸をさらに含むことにより行われてもよい。ルイス酸の具体例としては、CuBrS(CH、CuI及びCuClなどが挙げられ、具体的には、CuIであってもよいが、これに限定されない。 Step (1-2) may be performed by further including a Lewis acid as a catalyst. Specific examples of the Lewis acid include CuBrS (CH 3 ) 2 , CuI, and CuCl 2. Specifically, CuI may be used, but is not limited thereto.

段階(1)の後に、製造された化合物を単離、精製、及び濃縮する少なくとも1つの段階をさらに行ってもよいが、これに限定されない。例えば、例示的な実施形態によれば、段階(1)の製造された化合物を有機溶媒を用いて抽出し、得られた有機層をEDTA水溶液及び20%塩化ナトリウム水溶液を使用して洗浄して、続いて硫酸ナトリウムで乾燥し、濾過した。前記ろ液を濃縮して生成された化合物を得た。   Step (1) may be further followed by at least one step of isolating, purifying, and concentrating the produced compound, but is not limited thereto. For example, according to an exemplary embodiment, the prepared compound of step (1) is extracted using an organic solvent, and the resulting organic layer is washed using an aqueous EDTA solution and a 20% aqueous sodium chloride solution. Followed by drying over sodium sulfate and filtration. The filtrate was concentrated to obtain the produced compound.

本発明の製造方法において、段階(2)は、段階(1)で得られたハロゲン、例えば、クロロを含む化合物のクロロ基をアジドに置換して行われてもよい。   In the production method of the present invention, step (2) may be carried out by substituting the chloro group of the halogen-containing compound obtained in step (1), such as chloro, with an azide.

段階(2)の溶媒は、限定されず、アジド置換において一般的に用いられる任意の有機溶媒であってもよい。例えば、前記溶媒はジメチルホルムアミドであってもよいが、これに限定されない。   The solvent of step (2) is not limited and may be any organic solvent commonly used in azide substitution. For example, the solvent may be dimethylformamide, but is not limited thereto.

一方、段階(2)は、70℃〜100℃の温度、例えば、80℃〜90℃または80℃〜85℃で行われてもよいが、これに限定されない。   Meanwhile, step (2) may be performed at a temperature of 70 ° C. to 100 ° C., for example, 80 ° C. to 90 ° C. or 80 ° C. to 85 ° C., but is not limited thereto.

段階(2)の後に、製造された化合物を単離、精製、及び濃縮する少なくとも1つの段階をさらに行ってもよいが、これに限定されない。例えば、例示的な実施形態によれば、段階(2)の製造された化合物を有機溶媒を使用して抽出し、得られた有機層は塩酸水溶液、5%重炭酸ナトリウム水溶液、及び10%塩化ナトリウム水溶液を用いて洗浄し、続いて硫酸ナトリウムで乾燥させ、濾過した。前記ろ液を濃縮して生成された化合物を得た。   After step (2), at least one step of isolating, purifying, and concentrating the prepared compound may be further performed, but is not limited thereto. For example, according to an exemplary embodiment, the compound produced in step (2) is extracted using an organic solvent, and the resulting organic layer is extracted with aqueous hydrochloric acid, 5% aqueous sodium bicarbonate, and 10% chloride. Wash with aqueous sodium followed by drying over sodium sulfate and filtering. The filtrate was concentrated to obtain the produced compound.

具体的に、段階(3)は、トリフェニルホスフィンによる環化によって一般式(3-1)のアジリジニル基を形成する段階(3-1);及び段階(3-1)で得られたアジリジニル基を含む化合物とジ−tert-ブチルジカーボネートとを反応させることによってアミノ基に保護基を導入する段階(3-2)により行うことができる。   Specifically, the step (3) includes the step (3-1) of forming an aziridinyl group of the general formula (3-1) by cyclization with triphenylphosphine; and the aziridinyl group obtained in the step (3-1). Can be carried out by the step (3-2) of introducing a protecting group into an amino group by reacting a compound containing bis and di-tert-butyl dicarbonate.

式中、Rは前記で定義したものと同じである。 In the formula, R is the same as defined above.

例えば、Rはエチルであってもよい。   For example, R may be ethyl.

すなわち、一般式(3)の化合物のヒドロキシ基及びアジド基を縮合してアミノ基を含む環構造であるアジリジニル基を形成した後、前記アジリジニル基のアミノ基にtert−ブチル保護基を導入してもよい。   That is, after the hydroxy group and the azide group of the compound of the general formula (3) are condensed to form an aziridinyl group that is a ring structure containing an amino group, a tert-butyl protecting group is introduced into the amino group of the aziridinyl group. Also good.

段階(3-2)は、4−ジメチルアミノピリジン及びヨウ素(I)のような触媒、またはトリエタノールアミド(TEA)、N,N−ジイソプロピルエチルアミン(DIEA)、及びNaHCOのようなアルカリ性物質をさらに含むことによって行われてもよいが、これに限定されない。 Step (3-2) is a catalyst such as 4-dimethylaminopyridine and iodine (I 2 ) or an alkaline substance such as triethanolamide (TEA), N, N-diisopropylethylamine (DIEA), and NaHCO 3. However, the present invention is not limited to this.

例えば、段階(3)は、溶媒としてアセトニトリル、トルエン、またはそれらの混合物を用いて行われてもよい。具体的に、溶媒はアセトニトリルであってもよいが、これに限定されない。   For example, step (3) may be performed using acetonitrile, toluene, or a mixture thereof as a solvent. Specifically, the solvent may be acetonitrile, but is not limited thereto.

また、段階(3-1)は、55℃〜70℃の温度、具体的には60℃〜65℃で行われてもよいが、これに限定されない。   In addition, the step (3-1) may be performed at a temperature of 55 ° C. to 70 ° C., specifically 60 ° C. to 65 ° C., but is not limited thereto.

また、段階(3−2)は、20℃〜30℃の温度、具体的には20℃〜25℃で行われてもよいが、これに限定されない。   The step (3-2) may be performed at a temperature of 20 ° C. to 30 ° C., specifically, 20 ° C. to 25 ° C., but is not limited thereto.

段階(4)の開環は、アセトニトリル、テトラヒドロフラン、トルエン、またはそれらの混合物を溶媒として用いて行われてもよい。具体的には、前記溶媒はアセトニトリルであってもよいが、これに限定されない。   Ring opening in step (4) may be performed using acetonitrile, tetrahydrofuran, toluene, or a mixture thereof as a solvent. Specifically, the solvent may be acetonitrile, but is not limited thereto.

また、段階(4)は、45℃〜55℃の温度、具体的には、50℃〜52℃で行われてもよいが、これに限定されない。   Further, step (4) may be performed at a temperature of 45 ° C. to 55 ° C., specifically, 50 ° C. to 52 ° C., but is not limited thereto.

一方、アミノ保護基を除去する段階(5)は、トリフルオロ酢酸、塩酸、メタノール性塩酸、またはそれらの混合物を用いて行われてもよい。具体的には、メタノール性塩酸が用いられてもよいが、これに限定されない。   On the other hand, the step (5) of removing the amino protecting group may be performed using trifluoroacetic acid, hydrochloric acid, methanolic hydrochloric acid, or a mixture thereof. Specifically, methanolic hydrochloric acid may be used, but is not limited thereto.

段階(5)は、溶媒として、メタノール、ジクロロメタン、テトラヒドロフラン、またはそれらの混合物、具体的にはメタノールを用いて行われてもよい。   Step (5) may be performed using methanol, dichloromethane, tetrahydrofuran, or a mixture thereof, specifically methanol, as a solvent.

一方、段階(5)で、メタノール性塩酸は、メタノール溶媒に塩化アセチルを混合することによって提供されてもよいが、これに限定されない。   Meanwhile, in step (5), the methanolic hydrochloric acid may be provided by mixing acetyl chloride with a methanol solvent, but is not limited thereto.

また、段階(5)は、45℃〜55℃の温度、具体的には、50℃〜52℃で行われてもよいが、これに限定されない。   Further, step (5) may be performed at a temperature of 45 ° C. to 55 ° C., specifically 50 ° C. to 52 ° C., but is not limited thereto.

さらに、段階(4)及び(5)が独立して完了された後に、段階(4)及び(5)は、製造された化合物を結晶化するための、それぞれの段階(4-1)または(5-1)のいずれか、または両方の段階をさらに含んでもよい。   Further, after steps (4) and (5) are completed independently, steps (4) and (5) are used to crystallize the produced compound in the respective steps (4-1) or ( Either or both of the steps of 5-1) may be further included.

例えば、段階(4-1)は、エタノール、酢酸エチル、またはそれらの混合物を溶媒として用いて行ってもよい。具体的には、一般式(5)の化合物はエタノールと酢酸エチルとの混合物を溶媒として用いて結晶化させてもよいが、これに限定されない。   For example, step (4-1) may be performed using ethanol, ethyl acetate, or a mixture thereof as a solvent. Specifically, the compound of the general formula (5) may be crystallized using a mixture of ethanol and ethyl acetate as a solvent, but is not limited thereto.

一方、段階(5-1)は、メタノール、アセトン、メチルtert−ブチルエーテル、またはそれらの混合物を溶媒として用いて行われてもよい。具体的には、一般式(6)の化合物はメチルtert−ブチルエーテルを溶媒として用いて結晶化させてもよいが、これに限定されない。   Meanwhile, step (5-1) may be performed using methanol, acetone, methyl tert-butyl ether, or a mixture thereof as a solvent. Specifically, the compound of the general formula (6) may be crystallized using methyl tert-butyl ether as a solvent, but is not limited thereto.

本発明の製造方法は、合理的な価格の原料及び簡単な反応プロセスを用いることで(S)−N−(2-アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の効率的かつ経済的な製造を可能にし、またその商業的大量生産に有用に適用することができる。 The production method of the present invention uses (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2- by using a reasonably priced raw material and a simple reaction process. It enables efficient and economical production of diamine trihydrochloride and can be usefully applied to its commercial mass production.

以下、本発明は添付した図面を参照して詳細に説明する。しかしながら、本明細書に開示された例示的な実施形態は例示目的のためだけのものであり、本発明の範囲を限定するものとして解釈されるべきではない。   Hereinafter, the present invention will be described in detail with reference to the accompanying drawings. However, the exemplary embodiments disclosed herein are for illustrative purposes only and should not be construed as limiting the scope of the invention.

以下、具体的な開示のない試料及び溶媒は、Sigma - Aldrich Koreaから購入し、H−NMR分光法は、Bruker 400MHz NMR分光計を用いて実施した。 Hereinafter, samples and solvents without specific disclosure were purchased from Sigma-Aldrich Korea, and 1 H-NMR spectroscopy was performed using a Bruker 400 MHz NMR spectrometer.

以下の反応式に従って、実施例1〜5を行った。   Examples 1 to 5 were performed according to the following reaction formula.

実施例1:(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オールの製造
窒素雰囲気で置換した反応器中で、マグネシウム(14.50g、596.84mmol)を600mLのTHFに加え、混合物を撹拌して溶解させた。温度を20℃〜30℃に保ちながら、4−ブロモフェネトール(120.0g、596.84mmol)をゆっくり加えた。滴下終了後、温度を60℃に上げ、混合物を2時間攪拌してから−5℃に冷却し、続いてヨウ化銅(0.76g、2.98mmol)を加えて混合物をさらに30分間攪拌した。その後、(R)−エピクロロヒドリン(49.70g、537.15mmol)をゆっくり加え、混合物を室温で1時間撹拌した。反応終了後、5℃に温度を下げ、塩酸水溶液(3M、600mL)及びイソプロピルエーテル(360mL)を添加して層に分離した。有機層を10%EDTA水溶液(480mL)及び20%塩化ナトリウム水溶液(240mL)で2回洗浄し、硫酸ナトリウムで乾燥し、混合物をろ過した。ろ液を濃縮して表題化合物である(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オール(123.2g、収率100%)を収得した。
Example 1: Preparation of (R) -1-chloro-3- (4-ethoxyphenyl) propan-2-ol In a reactor purged with nitrogen atmosphere, magnesium (14.50 g, 596.84 mmol) was added to 600 mL. In addition to THF, the mixture was stirred to dissolve. 4-Bromophenetole (120.0 g, 596.84 mmol) was slowly added while maintaining the temperature at 20-30 ° C. After the addition was complete, the temperature was raised to 60 ° C. and the mixture was stirred for 2 hours and then cooled to −5 ° C., followed by addition of copper iodide (0.76 g, 2.98 mmol) and the mixture was stirred for an additional 30 minutes. . (R) -epichlorohydrin (49.70 g, 537.15 mmol) was then added slowly and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the temperature was lowered to 5 ° C., and aqueous hydrochloric acid (3M, 600 mL) and isopropyl ether (360 mL) were added to separate the layers. The organic layer was washed twice with 10% aqueous EDTA solution (480 mL) and 20% aqueous sodium chloride solution (240 mL), dried over sodium sulfate, and the mixture was filtered. The filtrate was concentrated to obtain the title compound (R) -1-chloro-3- (4-ethoxyphenyl) propan-2-ol (123.2 g, yield 100%).

H−NMR(CDCl、400MHz):δ(ppm)1.41(t、3H)、2.17(d、1H)、2.83(d、2H)、3.49〜3.61(m、2H)、4.00〜4.04(m、3H)、6.85(d、2H)、7.14(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.41 (t, 3H), 2.17 (d, 1H), 2.83 (d, 2H), 3.49 to 3.61 ( m, 2H), 4.00 to 4.04 (m, 3H), 6.85 (d, 2H), 7.14 (d, 2H).

実施例2:(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オールの製造
実施例1で製造した(R)−1−クロロ−3−(4−エトキシフェニル)プロパン−2−オール(115.33g、537.15mmol)をジメチルホルムアミド580mLに加え、混合物を撹拌して溶解させた。その後、ヨウ化ナトリウム(8.05g、53.72mmol)とアジ化ナトリウム(69.85g、1074.39mmol)とをこれに添加した。反応器内の温度を85℃に上げ、16時間攪拌した。反応終了後、混合物を室温まで冷却し、精製水580mL及びイソプロピルエーテル580mLを添加して層に分離した。その後、前記得られた水層をさらにイソプロピルエーテル(190mL)で2回抽出した。回収した有機層を塩酸水溶液(1M、580mL)、5%炭酸水素ナトリウム水溶液(580mL)、及び10%塩化ナトリウム水溶液(580mL)で洗浄し、硫酸ナトリウムで乾燥し、混合物を濾過した。ろ液を濃縮して表題化合物である(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オール(113.5g、収率95.5%)を収得した。
Example 2: Production of (R) -1-azido-3- (4-ethoxyphenyl) propan-2-ol (R) -1-chloro-3- (4-ethoxyphenyl) propane produced in Example 1 2-ol (115.33 g, 537.15 mmol) was added to 580 mL of dimethylformamide and the mixture was stirred to dissolve. Then sodium iodide (8.05 g, 53.72 mmol) and sodium azide (69.85 g, 107.39 mmol) were added thereto. The temperature in the reactor was raised to 85 ° C. and stirred for 16 hours. After completion of the reaction, the mixture was cooled to room temperature, and purified water (580 mL) and isopropyl ether (580 mL) were added to separate the layers. Thereafter, the obtained aqueous layer was further extracted twice with isopropyl ether (190 mL). The collected organic layer was washed with aqueous hydrochloric acid solution (1M, 580 mL), 5% aqueous sodium hydrogen carbonate solution (580 mL), and 10% aqueous sodium chloride solution (580 mL), dried over sodium sulfate, and the mixture was filtered. The filtrate was concentrated to obtain the title compound (R) -1-azido-3- (4-ethoxyphenyl) propan-2-ol (113.5 g, yield 95.5%).

H - NMR(CDCl、400MHz):δ(ppm)1.41(t、3H)、1.97(d、1H)、2.71−2.79(m、2H)、3.28(dd、1H)、3.38(dd、1H) 、3.94−4.01(m、1H)、4.04(q、2H)、6.86(d、2H)、7.10(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.41 (t, 3H), 1.97 (d, 1H), 2.71-2.79 (m, 2H), 3.28 ( dd, 1H), 3.38 (dd, 1H), 3.94-4.01 (m, 1H), 4.04 (q, 2H), 6.86 (d, 2H), 7.10 (d 2H).

実施例3:(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレートの製造
窒素雰囲気に置換した反応器中で、実施例2で製造した(R)−1−アジド−3−(4−エトキシフェニル)プロパン−2−オール(113.0g、510.71mmol)をアセトニトリル(AN、1130mL)に加え、混合物を撹拌し、続いてトリフェニルホスフィン(PPh、120.56g、459.64mmol)を加えて室温で2時間撹拌し、4時間還流した。反応完了後、混合物を20℃に冷却し、4−ジメチルアミノピリジン(DMAP、0.62g、122.17mmol)及びジ−tert−ブチルジカーボネート((Boc)O、100.32g、459.64mmol)をゆっくり加え、混合物を30分間撹拌した。前記混合物に過酸化水素(11.60g、102.14mmol)を加えて、さらに30分間撹拌した後、生成物を濃縮し、アセトニトリルを除去した。得られた濃縮物にヘプタン(1130mL)を入れ、20℃〜25℃で30分間攪拌した後、前記生成物をろ過した。ろ液を濃縮して表題化合物である(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレート(113.05g、収率93.9%)を収得した。
Example 3: Preparation of (S) -tert-butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (R) -1-Azide prepared in Example 2 in a reactor purged with nitrogen atmosphere -3- (4-Ethoxyphenyl) propan-2-ol (113.0 g, 510.71 mmol) was added to acetonitrile (AN, 1130 mL) and the mixture was stirred, followed by triphenylphosphine (PPh 3 , 120.56 g). 459.64 mmol) was added and stirred at room temperature for 2 hours and refluxed for 4 hours. After completion of the reaction, the mixture was cooled to 20 ° C. and 4-dimethylaminopyridine (DMAP, 0.62 g, 122.17 mmol) and di-tert-butyl dicarbonate ((Boc) 2 O, 100.32 g, 458.64 mmol). ) Was added slowly and the mixture was stirred for 30 minutes. Hydrogen peroxide (11.60 g, 102.14 mmol) was added to the mixture and stirred for an additional 30 minutes before the product was concentrated to remove acetonitrile. Heptane (1130 mL) was added to the resulting concentrate and stirred at 20 ° C. to 25 ° C. for 30 minutes, and then the product was filtered. The filtrate was concentrated to obtain the title compound (S) -tert-butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (113.05 g, yield 93.9%).

H - NMR(CDCl、400MHz):δ(ppm)1.39−1.45(m、12H)、2.01(d、1H)、2.29(d、1H)、2.57−2.62(m、2H)、2.91(q、 1H)、4.02(q、2H)、6.84(d、2H)、7.20(d、2H)。 1 H-NMR (CDCl 3 , 400 MHz): δ (ppm) 1.39-1.45 (m, 12H), 2.01 (d, 1H), 2.29 (d, 1H), 2.57- 2.62 (m, 2H), 2.91 (q, 1H), 4.02 (q, 2H), 6.84 (d, 2H), 7.20 (d, 2H).

実施例4:(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩の製造
実施例3で製造した(S)−tert−ブチル2−(4−エトキシベンジル)アジリジン−1−カルボキシレート(133.05g、479.70mmol)をアセトニトリル(400mL)に加えて、混合物を攪拌して溶解させた後、エチレンジアミン(432.45g、7195.52mmol)を加え、50℃で6時間撹拌した。反応終了後、生成物を濃縮し、内部温度を5℃に下げて、塩酸水溶液(2M、480mL)及び酢酸エチル(266mL)を添加して層に分離した。水層に50%水酸化ナトリウム水溶液(200mL)を加え、混合物を酢酸エチル(530mL)で分離した。有機層を20%塩化ナトリウム(266mL)で洗浄し、硫酸ナトリウムで乾燥して、混合物を濾過した。ろ液を50℃で真空乾燥して表題化合物である(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩(135.5g、収率68.8% )を収得した。
Example 4: Preparation of (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (S)-prepared in Example 3 tert-Butyl 2- (4-ethoxybenzyl) aziridine-1-carboxylate (133.05 g, 479.70 mmol) was added to acetonitrile (400 mL) and the mixture was stirred to dissolve, followed by ethylenediamine (432.45 g , 7195.52 mmol), and the mixture was stirred at 50 ° C. for 6 hours. After completion of the reaction, the product was concentrated, the internal temperature was lowered to 5 ° C., aqueous hydrochloric acid (2M, 480 mL) and ethyl acetate (266 mL) were added and the layers were separated. To the aqueous layer was added 50% aqueous sodium hydroxide solution (200 mL), and the mixture was separated with ethyl acetate (530 mL). The organic layer was washed with 20% sodium chloride (266 mL), dried over sodium sulfate and the mixture was filtered. The filtrate was dried in vacuo at 50 ° C. and the title compound (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (135 0.5 g, yield 68.8%).

H−NMR(DO、400MHz):δ(ppm)1.02(s、2H)、1.14(s、9H)、1.24(t、3H)、2.46(dd、1H)、2.82(dd、1H)、3.07(t、1H)、3.25−3.39(m、6H)、3.94−4.00(m、3H)、6.83(d、2H)、7.10(d、2H)。 1 H-NMR (D 2 O, 400 MHz): δ (ppm) 1.02 (s, 2H), 1.14 (s, 9H), 1.24 (t, 3H), 2.46 (dd, 1H ), 2.82 (dd, 1H), 3.07 (t, 1H), 3.25-3.39 (m, 6H), 3.94-4.00 (m, 3H), 6.83 ( d, 2H), 7.10 (d, 2H).

実施例5:(S)−N−(2−アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造
反応器に、メタノール(950mL)及び塩化アセチル(77.75g、990.55mmol)を加え、混合物を撹拌して溶解させた。この溶液に、実施例4で製造した(S)−tert−ブチル1−(2−アミノエチルアミノ)−3−(4−エトキシフェニル)プロパン−2−イルカルバメート二塩酸塩(135.5g、330.18mmol)を加え、混合物を50℃で1時間撹拌した。反応終了後、メチルtert−ブチルエーテル(950mL)を加え、混合物を結晶化して濾過した。 得られた結晶を50℃で真空乾燥して表題化合物である(S)−N−(2−アミノエチル)−3−(4−エトキシフェニル)プロパン−1,2−ジアミン三塩酸塩 (105.2g、収率99.8%)を収得した。
Example 5: Preparation of (S) -N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride A reactor was charged with methanol (950 mL) and acetyl chloride ( 77.75 g, 990.55 mmol) was added and the mixture was stirred to dissolve. To this solution was added (S) -tert-butyl 1- (2-aminoethylamino) -3- (4-ethoxyphenyl) propan-2-ylcarbamate dihydrochloride (135.5 g, 330) prepared in Example 4. .18 mmol) was added and the mixture was stirred at 50 ° C. for 1 h. After completion of the reaction, methyl tert-butyl ether (950 mL) was added, and the mixture was crystallized and filtered. The obtained crystals were vacuum-dried at 50 ° C. and the title compound (S) —N 1- (2-aminoethyl) -3- (4-ethoxyphenyl) propane-1,2-diamine trihydrochloride (105 .2 g, yield 99.8%).

H−NMR(DO、400MHz):δ(ppm)1.38(t、3H)、3.00(dd、1H)、3.17(dd、1H)、3.43〜3.58(m、6H)、3.94〜4.01(m、 1H)、4.13(q、2H)、7.03(d、2H)、7.31(d、2H)。
1 H-NMR (D 2 O, 400 MHz): δ (ppm) 1.38 (t, 3H), 3.00 (dd, 1H), 3.17 (dd, 1H), 3.43 to 3.58 (M, 6H), 3.94 to 4.01 (m, 1H), 4.13 (q, 2H), 7.03 (d, 2H), 7.31 (d, 2H).

Claims (21)

下記段階を含む(S)-N−(2-アミノエチル)-3-(4-アルコキシフェニル)プロパン-1,2-ジアミン三塩酸塩の製造方法:
(1)一般式(1)の化合物のグリニャールカップリングによって一般式(2)の化合物を製造する段階;
(2)アジ化ナトリウムとの反応において、一般式(2)の化合物をアジド置換によって一般式(3)の化合物を製造する段階;
(3)トリフェニルホスフィンを用いて一般式(3)の化合物を環化によってアミノ保護基により保護されたアミノ基を有する一般式(4)のアジリジン誘導体を製造する段階;
(4)一般式(4)の化合物を開環することによって一般式(5)の化合物を製造する段階;及び
(5)一般式(5)の化合物のアミノ保護基を除去するための反応によって一般式(6)の化合物を製造する段階:
(式中、Xはブロモまたはクロロであり、RはC1-6アルキルである。)。
A process for producing (S) -N 1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride comprising the following steps:
(1) producing a compound of general formula (2) by Grignard coupling of the compound of general formula (1);
(2) a step of producing a compound of the general formula (3) by azide substitution of the compound of the general formula (2) in the reaction with sodium azide;
(3) A step of producing an aziridine derivative of the general formula (4) having an amino group protected by an amino protecting group by cyclization of the compound of the general formula (3) with triphenylphosphine;
(4) producing a compound of general formula (5) by ring-opening the compound of general formula (4); and (5) by a reaction to remove the amino protecting group of the compound of general formula (5). Step for producing a compound of the general formula (6):
(Wherein X is bromo or chloro and R is C 1-6 alkyl).
段階(1)が、以下の段階:
(1-1)一般式(1)の化合物と金属または有機金属化合物とを反応させてグリニャール化合物を製造する段階;及び
(1-2)前記グリニャール化合物と一般式(7)の化合物とを反応させる段階:
を含む、請求項1に記載の方法。
Stage (1) includes the following stages:
(1-1) reacting a compound of general formula (1) with a metal or organometallic compound to produce a Grignard compound; and (1-2) reacting the Grignard compound with a compound of general formula (7). Stage to make:
The method of claim 1 comprising:
段階(1)が、テトラヒドロフラン(THF)、1,4-ジオキサン、ジエチルエーテル、またはそれらの混合物を溶媒として用いて行われる、請求項1に記載の方法。 The method of claim 1, wherein step (1) is performed using tetrahydrofuran (THF), 1,4-dioxane, diethyl ether, or a mixture thereof as a solvent. 段階(1-1)が、20℃〜60℃の温度で行われる、請求項2に記載の方法。   The method according to claim 2, wherein step (1-1) is performed at a temperature of 20C to 60C. 段階(1-2)が、−20℃〜30℃の温度で行われる、請求項2に記載の方法。   The method according to claim 2, wherein step (1-2) is performed at a temperature of -20 ° C to 30 ° C. 段階(1-2)が、ルイス酸をさらに含むことによって行われる、請求項2に記載の方法。   The method according to claim 2, wherein step (1-2) is performed by further comprising a Lewis acid. 段階(2)が、ジメチルホルムアミドを溶媒として用いて行われる、請求項1に記載の方法。   The process according to claim 1, wherein step (2) is carried out using dimethylformamide as a solvent. 段階(2)が、70℃〜100℃の温度で行われる、請求項1に記載の方法。   The method according to claim 1, wherein step (2) is performed at a temperature of 70C to 100C. 段階(3)が、以下の段階:
(3-1)トリフェニルホスフィンによる環化によって一般式(3-1)のアジリジニル基を形成する段階;及び
(3-2)段階(3-1)により得られるアジリジニル基を含む化合物とジ-tert-ブチルジカーボネートとを反応させることによってアミノ基に保護基を導入する段階:
(式中、Rは請求項1に定義されたものと同じである。)
を含む、請求項1に記載の方法。
Stage (3) is the following stage:
(3-1) a step of forming an aziridinyl group of the general formula (3-1) by cyclization with triphenylphosphine; and (3-2) a compound containing an aziridinyl group obtained by the step (3-1) and di- introducing a protecting group into the amino group by reacting with tert-butyl dicarbonate:
(Wherein R is the same as defined in claim 1).
The method of claim 1 comprising:
段階(3-2)が、4-ジメチルアミノピリジン及びヨウ素(I)から選択される触媒、またはトリエタノールアミド(TEA)、N、N-ジイソプロピルエチルアミン(DIEA)、及びNaHCOから選択されるアルカリ性物質をさらに含むことによって行われる、請求項9に記載の方法。 Step (3-2) is selected from a catalyst selected from 4-dimethylaminopyridine and iodine (I 2 ), or triethanolamide (TEA), N, N-diisopropylethylamine (DIEA), and NaHCO 3 The method according to claim 9, wherein the method is performed by further comprising an alkaline substance. 段階(3)が、アセトニトリル、トルエンまたはそれらの混合物を溶媒として用いて行われる、請求項1に記載の方法。   The process according to claim 1, wherein step (3) is carried out using acetonitrile, toluene or a mixture thereof as a solvent. 段階(3-1)が、55℃〜70℃の温度で行われる、請求項9に記載の方法。   The method according to claim 9, wherein the step (3-1) is performed at a temperature of 55C to 70C. 段階(3-2)が、20℃〜30℃の温度で行われる、請求項9に記載の方法。   The method according to claim 9, wherein step (3-2) is performed at a temperature of 20C to 30C. 段階(4)が、アセトニトリル、テトラヒドロフラン、トルエンまたはそれらの混合物を溶媒として用いて行われる、請求項1に記載の方法。   The process according to claim 1, wherein step (4) is carried out using acetonitrile, tetrahydrofuran, toluene or mixtures thereof as a solvent. 段階(4)が、45℃〜55℃の温度で行われる、請求項1に記載の方法。   The process according to claim 1, wherein step (4) is carried out at a temperature between 45C and 55C. 段階(5)の反応が、トリフルオロ酢酸、塩酸、メタノール性塩酸、またはそれらの混合物により行われる、請求項1に記載の方法。   The process according to claim 1, wherein the reaction of step (5) is carried out with trifluoroacetic acid, hydrochloric acid, methanolic hydrochloric acid, or mixtures thereof. 段階(5)が、メタノール、ジクロロメタン、テトラヒドロフラン、またはそれらの混合物を溶媒として用いて行われる、請求項1に記載の方法。   The method of claim 1, wherein step (5) is performed using methanol, dichloromethane, tetrahydrofuran, or a mixture thereof as a solvent. 段階(5)の反応が、メタノール溶媒中で塩化アセチルにより行われる、請求項1に記載の方法。   The process according to claim 1, wherein the reaction of step (5) is carried out with acetyl chloride in a methanol solvent. 段階(5)が、45℃〜55℃の温度で行われる、請求項1に記載の方法。   The process according to claim 1, wherein step (5) is carried out at a temperature between 45C and 55C. 段階(4)及び段階(5)が、製造された化合物を独立して結晶化するためのそれぞれの段階(4-1)または段階(5-1)のいずれか、または両方の段階をさらに含む、請求項1に記載の方法。   Step (4) and Step (5) further comprise either or both of the respective steps (4-1) or (5-1) for independently crystallizing the prepared compound. The method of claim 1. 段階(4-1)が、エタノール、酢酸エチル、またはそれらの混合物を溶媒として用いて行われて、段階(5-1)が、メタノール、アセトン、メチルtert-ブチルエーテル、またはそれらの混合物を溶媒として用いて行われる、請求項20に記載の方法。
Step (4-1) is performed using ethanol, ethyl acetate, or a mixture thereof as a solvent, and Step (5-1) is performed using methanol, acetone, methyl tert-butyl ether, or a mixture thereof as a solvent. 21. The method of claim 20, wherein the method is carried out using.
JP2019523878A 2016-11-04 2017-11-03 (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride Active JP6816274B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0146850 2016-11-04
KR1020160146850A KR101935636B1 (en) 2016-11-04 2016-11-04 A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride
PCT/KR2017/012389 WO2018084625A1 (en) 2016-11-04 2017-11-03 Method for preparation of (s)-n1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrochloride

Publications (2)

Publication Number Publication Date
JP2019534299A true JP2019534299A (en) 2019-11-28
JP6816274B2 JP6816274B2 (en) 2021-01-20

Family

ID=62076303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019523878A Active JP6816274B2 (en) 2016-11-04 2017-11-03 (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride

Country Status (5)

Country Link
US (1) US10501403B2 (en)
EP (1) EP3535237A4 (en)
JP (1) JP6816274B2 (en)
KR (1) KR101935636B1 (en)
WO (1) WO2018084625A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232199B (en) * 2018-09-13 2021-11-30 南京红杉生物科技有限公司 Synthesis method of 1-chloro-2- (4-ethoxybenzyl) -4-iodobenzene
CN109232279B (en) * 2018-10-24 2021-03-30 上海司太立制药有限公司 Purification method of gadoxetic acid disodium intermediate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526993A (en) * 2005-01-13 2008-07-24 ブリストル−マイヤーズ スクイブ カンパニー Glucocorticoid receptor, AP-1 and / or substituted heteroarylamide modulators of NF-κB activity and uses thereof
WO2009105668A1 (en) * 2008-02-20 2009-08-27 President And Fellows Of Harvard College Bicyclic guanidines, metal complexes thereof and their use in vapor deposition
JP2011512321A (en) * 2007-10-05 2011-04-21 アキュセラ, インコーポレイテッド Alkoxy compounds for disease treatment
JP2012522044A (en) * 2009-03-30 2012-09-20 ドン ア ファーマシューティカル カンパニー リミテッド Improved process for the preparation of dipeptidyl peptidase-IV inhibitors and intermediates
CN103896788A (en) * 2012-12-27 2014-07-02 齐鲁制药有限公司 Preparation method of S-1-(4-ethyoxylbenzyl)-3-azapentane-1,5-diaminetrihydrochloride

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100534976C (en) * 2007-01-16 2009-09-02 江苏省原子医学研究所 S-1-(4-ethoxybenzyl)-3-azapentane-1,5 diamine preparation method
CN104761461A (en) 2014-09-09 2015-07-08 山东富创医药科技有限公司 Preparation method of novel gadoxetate disodium intermediate
CN105001118A (en) * 2015-07-20 2015-10-28 湖南华腾制药有限公司 Method for preparing iodine-containing azido compound
WO2017208258A1 (en) * 2016-05-30 2017-12-07 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526993A (en) * 2005-01-13 2008-07-24 ブリストル−マイヤーズ スクイブ カンパニー Glucocorticoid receptor, AP-1 and / or substituted heteroarylamide modulators of NF-κB activity and uses thereof
JP2011512321A (en) * 2007-10-05 2011-04-21 アキュセラ, インコーポレイテッド Alkoxy compounds for disease treatment
WO2009105668A1 (en) * 2008-02-20 2009-08-27 President And Fellows Of Harvard College Bicyclic guanidines, metal complexes thereof and their use in vapor deposition
JP2012522044A (en) * 2009-03-30 2012-09-20 ドン ア ファーマシューティカル カンパニー リミテッド Improved process for the preparation of dipeptidyl peptidase-IV inhibitors and intermediates
CN103896788A (en) * 2012-12-27 2014-07-02 齐鲁制药有限公司 Preparation method of S-1-(4-ethyoxylbenzyl)-3-azapentane-1,5-diaminetrihydrochloride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ORGANIC LETTERS, vol. 8(15), JPN6020020661, 2006, pages 3371 - 3374, ISSN: 0004390440 *

Also Published As

Publication number Publication date
JP6816274B2 (en) 2021-01-20
EP3535237A4 (en) 2020-05-27
KR20180050471A (en) 2018-05-15
US20190284126A1 (en) 2019-09-19
WO2018084625A1 (en) 2018-05-11
EP3535237A1 (en) 2019-09-11
KR101935636B1 (en) 2019-01-07
US10501403B2 (en) 2019-12-10

Similar Documents

Publication Publication Date Title
TWI440635B (en) Process for the manufacture of an intermediate in the synthesis of dabigatran etexilate
KR101456438B1 (en) Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US10065933B2 (en) Method for preparing gadobutrol
JP2017088632A (en) Compounds useful in the synthesis of benzamide compounds
JP2016145214A (en) Method of synthesis of ferroquine by convergent reductive amination
CN112209938B (en) Preparation method and intermediate of 2-indoline spirocyclic ketone compound
JP6816274B2 (en) (S) Method for producing -N1- (2-aminoethyl) -3- (4-alkoxyphenyl) propane-1,2-diamine trihydrochloride
KR100674522B1 (en) Process for Preparation of Spirofluorenols
KR101427221B1 (en) Proces for purifying fluvoxamine free base and process for preparing high purity fluvoxamine maleate using the same
KR101520187B1 (en) A method for preparation of an intermediate of iopromide
CN113072514A (en) Preparation method of cycleanine and intermediate thereof
JP5279449B2 (en) Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride
KR101974388B1 (en) Alkyl diethylene triamine derivatives and a process of the preparation thereof
KR102559870B1 (en) Method for preparing carbamate compound
KR20180050091A (en) A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride
CN110418797B (en) Method for preparing ketolide compound
KR101085170B1 (en) Method of Preparing S-Rivastigmine
WO2023100110A1 (en) Process for preparing brivaracetam
CN117603094A (en) Synthesis method of amino-protected 2-aminomethyl olefine acid derivative
KR100929414B1 (en) Process for the preparation of thromium chloride
CN117677617A (en) Preparation method of hepatitis B virus nucleocapsid inhibitor
JPH0525111A (en) Production of aliphatic amide or its salt
CN111848423A (en) Preparation method of tert-butyl 3-oxocyclobutylcarbamate
JPH07285921A (en) Production of 2-amino-n-(beta-hydroxyphenethyl)acetamide derivative
JPH06102644B2 (en) Multi-coordinated aminotroponimine derivative and method for producing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190710

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200916

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201223

R150 Certificate of patent or registration of utility model

Ref document number: 6816274

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250